Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma
- 1 July 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (1), 29-37
- https://doi.org/10.1016/0002-9343(94)90045-0
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.Thorax, 1993
- Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in AsthmaNew England Journal of Medicine, 1992
- Long-Term Effects of a Long-Acting β2-Adrenoceptor Agonist, Salmeterol, on Airway Hyperresponsiveness in Patients with Mild AsthmaNew England Journal of Medicine, 1992
- Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol1Journal of Allergy and Clinical Immunology, 1990
- Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.Thorax, 1990
- Reproducibility of cardiac output measurement by cross sectional and Doppler echocardiography.Heart, 1988
- β-Adrenergic receptors and rhodopsin: shedding new light on an old subjectTrends in Pharmacological Sciences, 1986
- Assessment of cardiac output by the Doppler ultrasound technique alone.Heart, 1985
- $beta;-ADRENERGIC AGONIST RESISTANCE IN NORMAL HUMAN AIRWAYSThe Lancet, 1977
- EFFECT OF INTRAVENOUS PREDNISOLONE IN ASTHMATICS WITH DIMINISHED ADRENERGIC RESPONSIVENESSThe Lancet, 1975